365 related articles for article (PubMed ID: 22480736)
1. Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist.
Whittle BJ; Silverstein AM; Mottola DM; Clapp LH
Biochem Pharmacol; 2012 Jul; 84(1):68-75. PubMed ID: 22480736
[TBL] [Abstract][Full Text] [Related]
2. Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells.
Kiriyama M; Ushikubi F; Kobayashi T; Hirata M; Sugimoto Y; Narumiya S
Br J Pharmacol; 1997 Sep; 122(2):217-24. PubMed ID: 9313928
[TBL] [Abstract][Full Text] [Related]
3. Role of prostanoid IP and EP receptors in mediating vasorelaxant responses to PGI2 analogues in rat tail artery: Evidence for Gi/o modulation via EP3 receptors.
Orie NN; Clapp LH
Eur J Pharmacol; 2011 Mar; 654(3):258-65. PubMed ID: 21185823
[TBL] [Abstract][Full Text] [Related]
4. 7,7-Difluoroprostacyclin derivative, AFP-07, a highly selective and potent agonist for the prostacyclin receptor.
Chang CS; Negishi M; Nakano T; Morizawa Y; Matsumura Y; Ichikawa A
Prostaglandins; 1997 Feb; 53(2):83-90. PubMed ID: 9112287
[TBL] [Abstract][Full Text] [Related]
5. The mechanistic basis of prostacyclin and its stable analogues in pulmonary arterial hypertension: Role of membrane versus nuclear receptors.
Clapp LH; Gurung R
Prostaglandins Other Lipid Mediat; 2015 Jul; 120():56-71. PubMed ID: 25917921
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the recombinant human prostanoid DP receptor and identification of L-644,698, a novel selective DP agonist.
Wright DH; Metters KM; Abramovitz M; Ford-Hutchinson AW
Br J Pharmacol; 1998 Apr; 123(7):1317-24. PubMed ID: 9579725
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of PGI2 mimetics used clinically on the vasorelaxation of human pulmonary arteries and veins, role of the DP-receptor.
Benyahia C; Boukais K; Gomez I; Silverstein A; Clapp L; Fabre A; Danel C; Leséche G; Longrois D; Norel X
Prostaglandins Other Lipid Mediat; 2013 Dec; 107():48-55. PubMed ID: 23850788
[TBL] [Abstract][Full Text] [Related]
8. Differential actions of the prostacyclin analogues treprostinil and iloprost and the selexipag metabolite, MRE-269 (ACT-333679) in rat small pulmonary arteries and veins.
Orie NN; Ledwozyw A; Williams DJ; Whittle BJ; Clapp LH
Prostaglandins Other Lipid Mediat; 2013 Oct; 106():1-7. PubMed ID: 23872196
[TBL] [Abstract][Full Text] [Related]
9. Regulation of prostacyclin and prostaglandin E(2) receptor mediated responses in adult rat dorsal root ganglion cells, in vitro.
Rowlands DK; Kao C; Wise H
Br J Pharmacol; 2001 May; 133(1):13-22. PubMed ID: 11325789
[TBL] [Abstract][Full Text] [Related]
10. Treprostinil inhibits the adhesion and differentiation of fibrocytes via the cyclic adenosine monophosphate-dependent and Ras-proximate protein-dependent inactivation of extracellular regulated kinase.
Nikam VS; Wecker G; Schermuly R; Rapp U; Szelepusa K; Seeger W; Voswinckel R
Am J Respir Cell Mol Biol; 2011 Oct; 45(4):692-703. PubMed ID: 21278326
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
12. Prostanoid EP₂ Receptors Are Up-Regulated in Human Pulmonary Arterial Hypertension: A Key Anti-Proliferative Target for Treprostinil in Smooth Muscle Cells.
Patel JA; Shen L; Hall SM; Benyahia C; Norel X; McAnulty RJ; Moledina S; Silverstein AM; Whittle BJ; Clapp LH
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30103548
[TBL] [Abstract][Full Text] [Related]
13. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
14. Role of the prostanoid EP4 receptor in iloprost-mediated vasodilatation in pulmonary hypertension.
Lai YJ; Pullamsetti SS; Dony E; Weissmann N; Butrous G; Banat GA; Ghofrani HA; Seeger W; Grimminger F; Schermuly RT
Am J Respir Crit Care Med; 2008 Jul; 178(2):188-96. PubMed ID: 18467507
[TBL] [Abstract][Full Text] [Related]
15. In vitro pharmacological characterization of the prostanoid receptor population in the non-pregnant porcine myometrium.
Cao J; Shayibuzhati M; Tajima T; Kitazawa T; Taneike T
Eur J Pharmacol; 2002 May; 442(1-2):115-23. PubMed ID: 12020689
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a second receptor for prostacyclin on human airway epithelial cells that mediates inhibition of CXCL9 and CXCL10 release.
Wilson SM; Sheddan NA; Newton R; Giembycz MA
Mol Pharmacol; 2011 Mar; 79(3):586-95. PubMed ID: 21173040
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of prostacyclins in pulmonary arterial hypertension.
Roman A; Barberà JA; Escribano P; Sala ML; Febrer L; Oyagüez I; Sabater E; Casado MA
Appl Health Econ Health Policy; 2012 May; 10(3):175-88. PubMed ID: 22452448
[TBL] [Abstract][Full Text] [Related]
18. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells.
Watanabe T; Satoh H; Togoh M; Taniguchi S; Hashimoto Y; Kurokawa K
J Cell Physiol; 1996 Nov; 169(2):401-9. PubMed ID: 8908208
[TBL] [Abstract][Full Text] [Related]
19. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
[TBL] [Abstract][Full Text] [Related]
20. Piglet saphenous vein contains multiple relaxatory prostanoid receptors: evidence for EP4, EP2, DP and IP receptor subtypes.
Wilson RJ; Giles H
Br J Pharmacol; 2005 Feb; 144(3):405-15. PubMed ID: 15655509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]